This page is the continuation of patient information in support of Section 6d.
PATIENT INFORMATION
American Cancer Society. Breast Cancer Facts and Figures. (Retrieved November 13th 2014): http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-030975.pdf
American Cancer Society. Breast Cancer Early Detection. (Retrieved November 14th 2014): http://www.cancer.org/cancer/breastcancer/moreinformation/breastcancerearlydetection/breast-cancer-early-detection-risk-factors-you-cannot-change
American Society for Clinical Oncology (ASCO). HER2 Testing Guidelines, 2013. (Retrieved November 14th 2014): http://jco.ascopubs.org/content/31/31/3997.full
The Cancer Prevention and Treatment Fund. (Retrieved November 6th 2014): http://www.stopcancerfund.org/p-breast-cancer/dcis-lcis-pre-cancer-and-other-stage-zero-breast-conditions-what-kind-of-treatment-if-any-is-needed/
BREASTCANCER.ORG. (Retrieved November 14th 2014): https://www.breastcancer.org/
HER2 Testing. Recommendations for Breast Cancer. (Retrieved 14th November 2014): https://www.cancer.net/cancer-types/breast-cancer/diagnosis
Information on immunohistochemistry may be found at: https://www.prosci-inc.com/resources/antibody-development-guide/what-is-immunohistochemistry/
NCCN Guidelines Version 3. (2013) Ductal Carcinoma in Situ. (Retrieved November 6th 2014). http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
National Cancer Institution. BRCA1 and BRCA2: Cancer Risk and Genetic Testing. (Retrieved November 14th 2014): http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA
National Health Service Breast Screening Programme (NHSBSP) 50: Cytology sub-group of the National Coordinating Committee for Breast Cancer Screening Pathology. (2001). Guidelines for cytology procedures and reporting in breast cancer screening. NHSBSP publication number 22. Sheffield: NHS Breast Screening Programme, (Retrieved November 20th 2014): https://www.gov.uk/government/collections/breast-screening-professional-guidance
National Health Service Breast Screening Programme (NHSBSP) 58: Guidelines for pathology reporting in breast disease. January 2005, amended October 2005.ISBN 1 84463 015 3. Summary and PDFs available. (Retrieved November 7th 2014): https://www.gov.uk/government/publications/breast-screening-pathology-reporting-of-breast-disease
Patient.co.uk. Evidence-based online information for patients. (Retrieved October 28th 2014): http://www.patient.co.uk/health/breast-screening
Patient Health England. NHS Breast Screening Programme. NHSBSP 49. Clinical Guidance for breast cancer screening assessment. June 2010 (Third Edition). (Retrieved 23rd October 2014): https://www.gov.uk/government/publications/breast-screening-clinical-guidelines-for-screening-management
United States Preventive Services Task Force (USPSTF) Breast Cancer Screening Recommendations, 2009. (Retrieved November 13th 2014): https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/breast-cancer-screening1
WHO. (2012). Classification of Breast Tumors, 4th Edition. (Retrieved November 13th 2014): http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=70&codcch=4004
